
Thermo Fisher Invests $4 Billion in Strategic Acquisitions Amidst 2025 Market Headwinds
Thermo Fisher Scientific Inc.Description
What this story covers
Thermo Fisher Scientific demonstrated resilience in 2025, leveraging 4 billion dollars in strategic acquisitions like Olink and Solventum’s filtration unit to drive growth in bioproduction and proteomics, while offsetting macroeconomic challenges in China through disciplined operational efficiency.
Story snapshot
CompanyThermo Fisher Scientific Inc.
TickerTMO
VariantStandard detailed
Duration13:21
Filing type10-K
PeriodAnnual 2025
IndustryHealthcare & Pharmaceuticals
Accession0000097745-26-000018
Sources1
Full Story Script
Content not available for this story.